Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors

BACKGROUND: Failure of procognitive drug trials in schizophrenia may reflect the clinical heterogeneity of schizophrenia, underscoring the need to identify biomarkers of treatment sensitivity. We used an experimental medicine design to test the procognitive effects of a putative procognitive agent,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Neuropsychopharmacol
Autori principali: Bhakta, Savita G, Light, Gregory A, Talledo, Jo A, Balvaneda, Bryan, Hughes, Erica, Alvarez, Alexis, Rana, Brinda K, Young, Jared W, Swerdlow, Neal R
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Regular Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716101/
https://ncbi.nlm.nih.gov/pubmed/29020372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyx074
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi